Claudia Bockstiegel

Claudia Bockstiegel

Director Director DIN 08690067
DIN 08690067 First appointment Apr 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2020
Shareholding value •••• Premium profile

About Claudia Bockstiegel

Data last updated:

Claudia Bockstiegel was a Director at Roche Products (India) Private Limited (2020–2024) and Director at Roche Diagnostics India Private Limited (2020–2024). The companies operate in Pharma and Healthcare.

DIN 08690067
Primary Designation Director
Industry Pharma
First Appointment 28 Apr 2020

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Apr 20201994₹1,296 Cr (FY 2024)Active
Director29 Jun 20201988₹1,869 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Roche Products (India) Private Limited
Roche Diagnostics India Private Limited
Premium access

Shareholding and investment profile for Claudia Bockstiegel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Claudia Bockstiegel

Claudia Bockstiegel was first appointed on 28 Apr 2020 as Director at Roche Products (India) Private Limited.

Claudia Bockstiegel held 2 earlier board appointments: Roche Products (India) Private Limited (Director, 28 Apr 2020 to 31 Aug 2024); Roche Diagnostics India Private Limited (Director, 29 Jun 2020 to 10 Sep 2024).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available